Disc Medicine Ownership | Who Owns Disc Medicine?
Disc Medicine Ownership Summary
Disc Medicine is owned by 15.81% institutional investors, 8.12% insiders, and 76.07% retail investors. Fmr is the largest institutional shareholder, holding 15.83% of IRON shares.
IRON Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Disc Medicine | 15.81% | 8.12% | 76.07% |
| Sector | Healthcare Stocks | 232.80% | 10.63% | -143.43% |
| Industry | Biotech Stocks | 379.48% | 10.37% | -289.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 5.59M | 15.83% | $357.23M |
| Ra capital management | 2.45M | 6.94% | $156.67M |
| Blackrock funding, inc. /de | 2.27M | 6.44% | $145.39M |
| Vanguard group | 1.77M | 5.02% | $140.37M |
| Wellington management group llp | 1.74M | 4.92% | $110.96M |
| State street | 1.70M | 4.81% | $108.59M |
| Price t rowe associates inc /md/ | 1.55M | 4.39% | $99.07M |
| Atlas venture life science advisors | 1.51M | 4.29% | $96.80M |
| Jpmorgan chase | 1.37M | 3.89% | $83.36M |
| Frazier life sciences management | 1.35M | 3.84% | $86.63M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 1.51M | 12.25% | $96.80M |
| Foresite capital management v | 374.07K | 8.83% | $23.92M |
| Checkpoint capital | 286.66K | 6.58% | $18.33M |
| Saturn v capital management | 449.93K | 5.21% | $28.77M |
| Palo alto investors lp | 401.72K | 3.93% | $25.69M |
| Opaleye management | 421.00K | 3.55% | $26.92M |
| Lion point capital, lp | 8.10K | 3.10% | $517.91K |
| Bvf inc/il | 1.27M | 2.59% | $81.35M |
| Tcg crossover management | 1.34M | 2.45% | $85.80M |
| Frazier life sciences management | 1.35M | 2.23% | $86.63M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 1.34M | 2.45% | 1.34M |
| Bvf inc/il | 1.27M | 2.59% | 622.31K |
| State street | 1.70M | 0.00% | 510.25K |
| Ra capital management | 2.45M | 1.66% | 474.09K |
| Bellevue group | 459.31K | 0.70% | 459.31K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 247.72K | 0.47% | -963.25K |
| First light asset management | - | - | -523.17K |
| Perceptive advisors | - | - | -450.74K |
| Bioimpact capital | - | - | -346.40K |
| Great point partners | - | - | -250.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bellevue group | 459.31K | 0.70% | 459.31K | $29.37M |
| Octagon capital advisors lp | 270.00K | 1.91% | 270.00K | $17.26M |
| Vanguard fiduciary trust | 217.44K | 0.00% | 217.44K | $13.90M |
| Silverarc capital management | 196.03K | 1.28% | 196.03K | $12.53M |
| Integral health asset management | 170.00K | 0.52% | 170.00K | $10.87M |
Sold Out
| Holder | Change |
|---|---|
| Srs capital advisors | -2.00 |
| Parallel advisors | -4.00 |
| Amundi | -5.00 |
| Corecap advisors | -9.00 |
| Stephens consulting | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 44 | -74.42% | 5,560,393 | -83.75% | 15 | 0.17% | 31 | -64.37% | 8 | -82.98% |
| Sep 30, 2025 | 51 | -66.45% | 3,188,170 | -90.64% | 9 | 0.10% | 26 | -73.20% | 13 | -63.89% |
| Jun 30, 2025 | 151 | -4.43% | 34,062,461 | 12.23% | 97 | 1.17% | 96 | -4.00% | 36 | 16.13% |
| Mar 31, 2025 | 159 | 1.27% | 33,141,259 | 24.71% | 99 | 1.26% | 100 | 13.64% | 32 | -27.27% |
| Dec 31, 2024 | 157 | 16.30% | 26,575,703 | -2.98% | 88 | 1.06% | 88 | 4.76% | 44 | 69.23% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 13, 2026 | Savage William Jacob | Chief Medical Officer | Sell | $146.98K |
| Apr 13, 2026 | Savage William Jacob | Chief Medical Officer | Sell | $233.47K |
| Apr 14, 2026 | Franchi Jean M. | Chief Financial Officer | Sell | $433.23K |
| Apr 13, 2026 | Franchi Jean M. | Chief Financial Officer | Sell | $27.60K |
| Mar 02, 2026 | Savage William Jacob | Chief Medical Officer | Sell | $287.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 4 |
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 58 |
| 2025 Q3 | - | 12 |
| 2025 Q2 | - | 4 |
IRON Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools